AveXis, Inc.
DelistedCIK 1652923fmd_1K2MAWDP648GENM0PX0VH6P5HYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2014 to Mar 31, 2018, 14 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|
| Net interest income | (0) | 0 | 0 | – |
| Research and development | 14 | 27 | 59 | 150 |
| Selling, general and administrative | 2 | 11 | 25 | 70 |
| Total operating expenses | – | 39 | 83 | 220 |
| Operating income | (15) | (39) | (83) | (220) |
| Other non-operating income (expense) | – | 0 | – | – |
| Income before taxes | (16) | (38) | (83) | (218) |
| Net income from continuing operations | (16) | (38) | (83) | – |
| Net income | (16) | (38) | (83) | (218) |